These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

158 related items for PubMed ID: 20116902

  • 1. Discovery of new cholesteryl ester transfer protein inhibitors via ligand-based pharmacophore modeling and QSAR analysis followed by synthetic exploration.
    Abu Khalaf R, Abu Sheikha G, Bustanji Y, Taha MO.
    Eur J Med Chem; 2010 Apr; 45(4):1598-617. PubMed ID: 20116902
    [Abstract] [Full Text] [Related]

  • 2. Discovery of new renin inhibitory leads via sequential pharmacophore modeling, QSAR analysis, in silico screening and in vitro evaluation.
    Al-Nadaf AH, Taha MO.
    J Mol Graph Model; 2011 Apr; 29(6):843-64. PubMed ID: 21376648
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Elaborate ligand-based modeling reveals new nanomolar heat shock protein 90α inhibitors.
    Al-Sha'er MA, Taha MO.
    J Chem Inf Model; 2010 Sep 27; 50(9):1706-23. PubMed ID: 20831219
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Pharmacophore and QSAR modeling of estrogen receptor beta ligands and subsequent validation and in silico search for new hits.
    Taha MO, Tarairah M, Zalloum H, Abu-Sheikha G.
    J Mol Graph Model; 2010 Jan 27; 28(5):383-400. PubMed ID: 19850503
    [Abstract] [Full Text] [Related]

  • 9. Discovery of DPP IV inhibitors by pharmacophore modeling and QSAR analysis followed by in silico screening.
    Al-Masri IM, Mohammad MK, Taha MO.
    ChemMedChem; 2008 Nov 27; 3(11):1763-79. PubMed ID: 18989859
    [Abstract] [Full Text] [Related]

  • 10. Discovery of new antifungal leads via pharmacophore modeling and QSAR analysis of fungal N-myristoyl transferase inhibitors followed by in silico screening.
    Taha MO, Qandil AM, Al-Haraznah T, Khalaf RA, Zalloum H, Al-Bakri AG.
    Chem Biol Drug Des; 2011 Sep 27; 78(3):391-407. PubMed ID: 21679375
    [Abstract] [Full Text] [Related]

  • 11. Elaborate ligand-based pharmacophore exploration and QSAR analysis guide the synthesis of novel pyridinium-based potent beta-secretase inhibitory leads.
    Al-Nadaf A, Abu Sheikha G, Taha MO.
    Bioorg Med Chem; 2010 May 01; 18(9):3088-115. PubMed ID: 20378363
    [Abstract] [Full Text] [Related]

  • 12. Discovery of novel CDK1 inhibitors by combining pharmacophore modeling, QSAR analysis and in silico screening followed by in vitro bioassay.
    Al-Sha'er MA, Taha MO.
    Eur J Med Chem; 2010 Sep 01; 45(9):4316-30. PubMed ID: 20638755
    [Abstract] [Full Text] [Related]

  • 13. Pharmacophore modeling, quantitative structure-activity relationship analysis, and shape-complemented in silico screening allow access to novel influenza neuraminidase inhibitors.
    Abu Hammad AM, Taha MO.
    J Chem Inf Model; 2009 Apr 01; 49(4):978-96. PubMed ID: 19341295
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. 2D Quantitative structure-activity relationship studies on a series of cholesteryl ester transfer protein inhibitors.
    Castilho MS, Guido RV, Andricopulo AD.
    Bioorg Med Chem; 2007 Sep 15; 15(18):6242-52. PubMed ID: 17604633
    [Abstract] [Full Text] [Related]

  • 16. Discovery of new nanomolar peroxisome proliferator-activated receptor γ activators via elaborate ligand-based modeling.
    Al-Najjar BO, Wahab HA, Tengku Muhammad TS, Shu-Chien AC, Ahmad Noruddin NA, Taha MO.
    Eur J Med Chem; 2011 Jun 15; 46(6):2513-29. PubMed ID: 21482446
    [Abstract] [Full Text] [Related]

  • 17. Discovery of new potent human protein tyrosine phosphatase inhibitors via pharmacophore and QSAR analysis followed by in silico screening.
    Taha MO, Bustanji Y, Al-Bakri AG, Yousef AM, Zalloum WA, Al-Masri IM, Atallah N.
    J Mol Graph Model; 2007 Mar 15; 25(6):870-84. PubMed ID: 17035054
    [Abstract] [Full Text] [Related]

  • 18. Ligand-based modelling followed by synthetic exploration unveil novel glycogen phosphorylase inhibitory leads.
    Habash M, Taha MO.
    Bioorg Med Chem; 2011 Aug 15; 19(16):4746-71. PubMed ID: 21788139
    [Abstract] [Full Text] [Related]

  • 19. Elaborate ligand-based modeling coupled with multiple linear regression and k nearest neighbor QSAR analyses unveiled new nanomolar mTOR inhibitors.
    Khanfar MA, Taha MO.
    J Chem Inf Model; 2013 Oct 28; 53(10):2587-612. PubMed ID: 24050502
    [Abstract] [Full Text] [Related]

  • 20. 2D and 3D QSAR models for identifying diphenylpyridylethanamine based inhibitors against cholesteryl ester transfer protein.
    Chen M, Yang X, Lai X, Gao Y.
    Bioorg Med Chem Lett; 2015 Oct 15; 25(20):4487-95. PubMed ID: 26346366
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.